Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trial.
Joao Pedro FerreiraJohn GregsonMichael BöhmPatrick RossignolFaiez ZannadStuart J PocockPublished in: Clinical cardiology (2021)
In SPRINT, an intensive therapy strategy achieving SBP <120 mmHg with a DBP ≥60 mmHg, and using ACEi/ARBs plus thiazides was associated with a lower event-rate.